N
Niek Dekker
Researcher at AstraZeneca
Publications - 74
Citations - 4409
Niek Dekker is an academic researcher from AstraZeneca. The author has contributed to research in topics: Active site & Bacterial outer membrane. The author has an hindex of 30, co-authored 69 publications receiving 3788 citations. Previous affiliations of Niek Dekker include Utrecht University.
Papers
More filters
Journal ArticleDOI
Thermofluor-based high-throughput stability optimization of proteins for structural studies.
Ulrika B. Ericsson,B. Martin Hallberg,B. Martin Hallberg,George T. DeTitta,Niek Dekker,Pär Nordlund,Pär Nordlund +6 more
TL;DR: A twofold increase in the number of crystallization leads was observed when the proteins were cocrystallized with stabilizing additives as compared with experiments without these additives, suggesting that thermofluor constitutes an efficient generic high-throughput method for identification of protein properties predictive of crystallizability.
Journal ArticleDOI
Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site.
Lucy Vandeputte-Rutten,R.Arjen Kramer,Jan Kroon,Jan Kroon,Niek Dekker,Niek Dekker,Maarten R. Egmond,Piet Gros +7 more
TL;DR: The crystal structure of OmpT from Escherichia coli is presented, which shows a 10‐stranded antiparallel β‐barrel that protrudes far from the lipid bilayer into the extracellular space and a novel proteolytic mechanism, involving a His-Asp dyad and an Asp—Asp couple that activate a putative nucleophilic water molecule.
Journal ArticleDOI
Structural evidence for dimerization-regulated activation of an integral membrane phospholipase.
H.J. Snijder,I. Ubarretxena-Belandia,I. Ubarretxena-Belandia,Mieke Blaauw,Kor H. Kalk,Hubertus M. Verheij,Maarten R. Egmond,Niek Dekker,Bauke W. Dijkstra +8 more
TL;DR: X-ray structures of monomeric and dimeric OMPLA from E. coli provide a detailed view of activation by dimerization of a membrane protein.
Journal ArticleDOI
Structural insight into allosteric modulation of protease-activated receptor 2
Robert K. Y. Cheng,Cédric Fiez-Vandal,Oliver Schlenker,Karl Edman,Birte Aggeler,Dean G. Brown,Giles A. Brown,Robert M. Cooke,Christoph E. Dumelin,A.S. Dore,Stefan Geschwindner,Christoph Grebner,Nils-Olov Hermansson,Ali Jazayeri,Patrik Johansson,Louis Leong,Rudi Prihandoko,Mathieu Rappas,Holly H. Soutter,Arjan Snijder,Linda Sundström,Benjamin Tehan,Peter E. Thornton,Dawn M. Troast,Giselle R. Wiggin,Andrei Zhukov,Fiona H. Marshall,Niek Dekker +27 more
TL;DR: Crystal structures of PAR2 in complex with two distinct antagonists and a blocking antibody provide a basis for the development of selective PAR2 antagonists for a range of therapeutic uses.
Journal ArticleDOI
G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent
Mohammed Jamshad,Jack Charlton,Yu-pin Lin,Sarah J Routledge,Zharain Bawa,Timothy J. Knowles,Michael Overduin,Niek Dekker,Timothy R. Dafforn,Roslyn M. Bill,David R. Poyner,Mark Wheatley +11 more
TL;DR: The first solubilization and purification of a functional GPCR [human adenosine A2A receptor (A2AR)], in the total absence of detergent at any stage, is reported, by exploiting spontaneous encapsulation by styrene maleic acid co-polymer direct from the membrane into a nanoscale SMA lipid particle (SMALP).